Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 17, 2025
Coherent Introduces 2D Collimator Array for Optical Circuit Switches
GlobeNewswire
·
March 17, 2025
PITTSBURGH, March 17, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announces the launch of its 2D Collimator Array, an advanced optical assembly designed for optical circuit switches (OCS). OCS technology is rapidly …
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
GlobeNewswire
·
March 17, 2025
Doubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five transactions in 2024 Completed two whole company acquisitions to unlock shareholder value Day One’s OJEMDA™ (tovorafenib) and Zevra’s …
ProHance Releases Global Productivity Benchmarking Report for 2023 & 2024
EIN Presswire
·
March 17, 2025
ProHance releases its 2023-24 Global Productivity Benchmarking Report, offering key insights into workforce efficiency, trends, and industry best practices BENGALURU, KARNATAKA, INDIA, March 17, 2025 /EINPresswire.com/ -- ProHance, a new-age workforce …
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results
GlobeNewswire
·
March 17, 2025
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential quarter improvement in revenue, gross …
A' Futuristic Design Award Announces Final Call for Entries, Deadline March 30, 2025
EIN Presswire
·
March 17, 2025
The prestigious A' Futuristic Design Award invites innovative designers and forward-thinking companies to submit groundbreaking projects before March 30, 2025 COMO, CO, ITALY, March 17, 2025 /EINPresswire.com/ -- The A' Futuristic Design Award, a highly …
Robex Announces the Closing of a US$130 Million Syndicated Facility Agreement With Sprott
GlobeNewswire
·
March 17, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, March 17, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (“Robex”, the “Company” or the “Issuer”) (TSXV: RBX) is pleased to announce the fulfilment of the initial …
NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
GlobeNewswire
·
March 17, 2025
PARIS and CAMBRIDGE, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering disruptive nanotherapeutic approaches to revolutionize treatment outcomes …
NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026
GlobeNewswire
·
March 17, 2025
PARIS et CAMBRIDGE, Mass., 17 mars 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …
APA Corporation and Partners Lagniappe Alaska and Oil Search Announce Significant Oil Discovery in Alaska’s North Slope at Sockeye-2 Exploration Well; Partners Proceeding with Further Evaluation and Testing
GlobeNewswire
·
March 17, 2025
HOUSTON, March 17, 2025 (GLOBE NEWSWIRE) -- APA Corporation (NYSE, Nasdaq: APA) and its partners Lagniappe Alaska, LLC, an Armstong company, and Oil Search (Alaska), LLC, a subsidiary of Santos Limited, today announced preliminary results of the Sockeye-2 …
Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 17, 2025
Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025 Commercial launch in the PRC of generic nintedanib for the treatment of IPF and avatrombopag maleate tablets for the treatment of CLD-associated thrombocytopenia expected …
Autoscope Technologies Corporation Announces Financial Results
GlobeNewswire
·
March 17, 2025
MINNEAPOLIS, March 17, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter and year ended December 31, 2024. Fourth Quarter 2024 Financial Summary Royalties increased 22 percent to $3.0 million …
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 17, 2025
BRISBANE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
GlobeNewswire
·
March 17, 2025
Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A albumin platform to achieve in vivo …
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
GlobeNewswire
·
March 17, 2025
WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads …
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 17, 2025
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 million Transaction expected to close by mid-2025 Upon close of sale of FibroGen China, cash runway extended into 2027 Initiation of the Phase 2 monotherapy …
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewswire
·
March 17, 2025
Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome autoimmune and …
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
GlobeNewswire
·
March 17, 2025
VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it has entered into a new Contract Manufacturing …
A' Robotics, Automaton and Automation Design Award Announces Last Entry Period for 2025 Competition
EIN Presswire
·
March 17, 2025
The prestigious A' Robotics, Automaton and Automation Design Award extends opportunities for robotics innovators to showcase excellence through last submissions COMO, CO, ITALY, March 17, 2025 /EINPresswire.com/ -- The A' Robotics, Automaton and …
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
GlobeNewswire
·
March 17, 2025
SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on March 25, 2025 at 4:30 pm …
BridgeBio Announces CFO Succession
GlobeNewswire
·
March 17, 2025
PALO ALTO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced that Thomas Trimarchi, Ph.D. has been appointed …